Peptide Therapeutics Market Size is Estimated to Reach USD 75.92 Billion by 2032, Growing at a CAGR of 6.0 %: Emergen Research

The global peptide therapeutics market is poised for substantial growth, with a projected revenue CAGR of 6.0% during the forecast period. Valued at USD 42.70 billion in 2022, this market is being propelled by a convergence of factors including escalating cancer rates, transformative peptide-based therapies, and innovative delivery systems.

Peptides, short chains of amino acids, are emerging as critical tools in combating a myriad of diseases and conditions. Their ability to target specific cells while sparing healthy tissue holds immense promise, particularly in cancer treatment.

We Have Recent Updates of Peptide Therapeutics Market in Sample Copy: https://www.emergenresearch.com/request-sample/2736

Key Market Drivers:
1. Escalating Prevalence of Cancer: With cancer as a leading global cause of mortality, peptide-based therapies are offering a beacon of hope. Their targeted approach minimizes collateral damage to healthy tissues.

2. Technological Advancements: Innovations such as peptide drug conjugates and cell-penetrating peptides are revolutionizing cancer treatment. These advancements enable precise targeting of cancer cells, enhancing therapeutic efficacy while reducing side effects.

3. Innovative Delivery Systems: Nanoparticles, liposomes, and other novel delivery systems are amplifying the effectiveness of peptide therapeutics. These technologies promise safer and more potent treatments for various diseases.

4. Rising Product Launches and Collaborations: Collaborations between industry leaders are fostering the development of new peptide drugs. Partnerships like Sumitovant's collaboration with Neochromosome are leveraging AI to accelerate drug discovery and commercialization.

Market Challenges:
Despite the promising outlook, the high cost of peptide drugs poses a significant challenge. Additionally, ensuring access to these therapies in low/middle-income countries remains an ongoing concern. Peptides also face limitations such as poor stability and short half-life, necessitating ongoing research and development efforts.

Segment Insights:

1. Innovative Peptides Lead the Way: The innovative peptide segment dominates the market, offering advantages like higher purity and greater clinical data. These peptides hold promise for treating chronic diseases like diabetes and cancer.

2. Steady Growth in Generic Peptides: Technological advancements are driving growth in the generic peptide segment. Competition among manufacturers is reducing prices, making peptide therapies more accessible to patients.

3. Dominance of Cancer Therapeutics: Cancer treatment remains the largest segment in the peptide therapeutics market. Targeting peptides are widely used in cancer therapeutics, with promising advancements like Cybrexa Therapeutics' CBX-15 offering new hope for patients.

4. Metabolic Disorders on the Rise: The metabolic disorder segment is witnessing steady growth, fueled by increasing prevalence of diseases like diabetes and obesity.

Route of Administration and Distribution Channels:

1. Parenteral Administration Prevails: Parenteral administration, delivering peptides directly into the bloodstream, dominates the market. This route ensures optimal absorption and efficacy, particularly for acute conditions.

2. In-house Manufacturing Gains Traction: In-house manufacturing allows companies greater control over peptide production, facilitating customization and efficient development processes.

3. Hospital Pharmacies Drive Distribution: Hospital pharmacies play a pivotal role in peptide therapeutics distribution, ensuring seamless patient care and collaboration with healthcare professionals.

The global peptide therapeutics market is poised for substantial growth, driven by technological advancements, rising disease prevalence, and collaborative efforts within the industry. As innovative therapies continue to emerge, the future looks promising for patients in need of targeted and effective treatments.

The global peptide therapeutics market is fairly fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective peptide therapeutics solutions.

To Visit Full Report & Table of Contents Peptide Therapeutics Market: https://www.emergenresearch.com/industry-report/peptide-therapeutics-market

Some major players included in the global peptide therapeutics market report are:
• AstraZeneca
• Amgen Inc.
• GSK plc.
• Pfizer Inc.
• Sanofi
• AbbVie Inc.
• Bristol Myers Squibb Company
• Eli Lilly and Company
• Novartis AG
• Baush Health companies Inc.

Peptide Therapeutics Latest Industry News

• On 22 June 2023, IRBM collaborated with Merck & Co. Inc. to continue their development in the peptide therapeutics area. The utilization of novel technologies, such as phage display peptide libraries and half-life extension strategies, has accelerated the development of peptide candidates with enhanced therapeutic potential. This collaboration has taken advantage of these novel technologies to develop peptide candidates that progress into the clinic.

• On 31 May 2022, Sapience Therapeutics announced the development of peptide therapeutics to address difficult-to-treat cancers.ST101, a first-in-class antagonist evaluated in the Phase 2 portion of an ongoing Phase 1-2 clinical study in patients with advanced unresectable and metastatic solid tumors. This is an advanced treatment for metastatic hormone-receptor positive breast cancer and castration-resistant prostate cancer.

Peptide Therapeutics Market Segment Analysis

For the purpose of this report, Emergen Research has segmented the global peptide therapeutics market on the basis of type, application, route of administrations, type of manufacturers, distribution channel, and region:

• Type Outlook (Revenue, USD Billion; 2019-2032)
o Innovative
o Generic

• Application Outlook (Revenue, USD Billion; 2019-2032)
o Metabolic Disorder
o Respiratory Disorders
o Cancer
o Cardiovascular
o Immunological
o Neurological Disorders
o Gastrointestinal (GI) Disorders
o Renal Disorders
o Others

• Route of Administration Outlook (Revenue, USD Billion; 2019-2032)
o Parenteral Route
o Pulmonary
o Oral Route
o Mucosal
o Others

• Type of manufacturers Outlook (Revenue, USD Billion; 2019-2032)
o In-house
o Outsourced

• Distribution Channel Outlook (Revenue, USD Billion; 2019-2032)
o Hospital Pharmacies
o Drug Store and Retail Pharmacies
o Online Pharmacies

Enquire for customization in Report @: https://www.emergenresearch.com/request-for-customization/2736

• Regional Outlook (Revenue, USD Billion; 2019-2032)
o North America
1. U.S.
2. Canada
o Europe
1. Germany
2. France
3. UK
4. Italy
5. Spain
6. Benelux
7. Russia
8. Rest of Europe
o Asia Pacific
1. China
2. Japan
3. South Korea
4. India
5. ASEAN Countries
6. Oceania
7. Rest of APAC
o Latin America
1. Brazil
2. Mexico
3. Rest of LATAM
o Middle East & Africa
1. GCC Countries
2. Israel
3. Turkey
4. South Africa
5. Rest of Middle East & Africa

Related Links:

Electrosurgical Devices Market https://www.biospace.com/article/electrosurgical-devices-market-size-to-reach-usd-7-62-billion-in-2027-industry-trend-rapid-advancements-in-electrosurgical-devices/
Artificial Intelligence in Healthcare Market https://www.biospace.com/article/artificial-intelligence-in-healthcare-market-trends-rising-focus-on-reducing-computing-hardware-costs-and-rapid-adoption-of-human-aware-ai-systems/
Alopecia Market https://www.biospace.com/article/alopecia-market-size-to-reach-usd-5-718-12-million-in-2028-industry-trend-rising-focus-on-physical-appearance-and-increasing-per-capita-income/
Cerebrospinal Fluid Management Market https://www.biospace.com/article/cerebrospinal-fluid-management-market-size-to-reach-usd-2-09-billion-in-2028-industry-trend-rapid-integration-of-advanced-sensors-in-cerebrospinal-fluid-csf-devices/
Inhalation and Nasal Spray Market https://www.biospace.com/article/inhalation-and-nasal-spray-market-size-to-reach-usd-46-79-billion-in-2028-industry-trends-increasing-risks-of-respiratory-diseases-among-the-geriatric-population-and-technological-advances-in-inhalation-devices/
Brachytherapy Market https://www.biospace.com/article/brachytherapy-market-size-to-reach-usd-548-8-million-in-2027-industry-trend-increasing-adoption-of-brachytherapy-over-conventional-treatments/

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.